ENSC — Ensysce Biosciences Share News
0.000.00%
Last trade - 00:00- $9.15m
- $8.35m
- $5.07m
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing
Ensysce Biosciences Q1 net loss widens, cash falls sharply
Ensysce Biosciences Q4 net loss narrows to $2.8 mln
Ensysce Biosciences reports Q3 net loss
Ensysce Biosciences Inc expected to post a loss of $1.18 a share - Earnings Preview
Ensysce Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Ensysce Biosciences Inc Announces 1-For-15 Reverse Stock Split
Ensysce Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Lumen Technologies, Insulet, PDD Holdings
U.S. STOCKS ON THE MOVE-Eli Lilly, JD.com, Super Micro Computer
U.S. STOCKS ON THE MOVE-Trinity Biotech, Cava Group, Paramount Global
Ensysce Biosciences rises on US government grant for its pain relief drug
Ensysce Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Ensysce Biosciences PF614 Phase 3 Protocol Being Finalized For Submission To FDA
Brief: Ensysce Biosciences Announces Partnership To Scale And Manufacture New Drug Candidate
Brief: Ensysce Biosciences Regains Compliance With Nasdaq